Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.128
+0.008 (0.72%)
Oct 29, 2025, 1:23 PM EDT - Market open
Rockwell Medical Market Cap
Rockwell Medical has a market cap or net worth of $38.84 million as of October 29, 2025. Its market cap has decreased by -63.60% in one year.
Market Cap
38.84M
Enterprise Value
34.32M
1-Year Change
-63.60%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since December 1, 1998, Rockwell Medical's market cap has increased from $7.80M to $38.84M, an increase of 397.96%. That is a compound annual growth rate of 6.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 38.60M | -41.43% |
| Dec 31, 2024 | 65.90M | 22.49% |
| Dec 29, 2023 | 53.80M | 355.93% |
| Dec 30, 2022 | 11.80M | -69.35% |
| Dec 31, 2021 | 38.50M | -59.26% |
| Dec 31, 2020 | 94.50M | -39.46% |
| Dec 31, 2019 | 156.10M | 21.20% |
| Dec 31, 2018 | 128.80M | -57.24% |
| Dec 29, 2017 | 301.20M | -10.76% |
| Dec 30, 2016 | 337.50M | -35.47% |
| Dec 31, 2015 | 523.00M | 16.69% |
| Dec 31, 2014 | 448.20M | 7.33% |
| Dec 31, 2013 | 417.60M | 143.50% |
| Dec 31, 2012 | 171.50M | 8.48% |
| Dec 30, 2011 | 158.10M | 14.57% |
| Dec 31, 2010 | 138.00M | 5.18% |
| Dec 31, 2009 | 131.20M | 126.21% |
| Dec 31, 2008 | 58.00M | -30.54% |
| Dec 31, 2007 | 83.50M | 2.08% |
| Dec 29, 2006 | 81.80M | 108.14% |
| Dec 30, 2005 | 39.30M | 46.10% |
| Dec 31, 2004 | 26.90M | -20.88% |
| Dec 31, 2003 | 34.00M | 608.33% |
| Dec 31, 2002 | 4.80M | -47.25% |
| Dec 31, 2001 | 9.10M | 152.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.27B |
| Johnson & Johnson | 456.68B |
| AbbVie | 402.17B |
| UnitedHealth Group | 328.86B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 218.72B |